Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Relling MV, Klein TE.

Clin Pharmacol Ther. 2011 Mar;89(3):464-7. doi: 10.1038/clpt.2010.279. Epub 2011 Jan 26. No abstract available.

2.

The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.

O'Donnell PH, Bush A, Spitz J, Danahey K, Saner D, Das S, Cox NJ, Ratain MJ.

Clin Pharmacol Ther. 2012 Oct;92(4):446-9. doi: 10.1038/clpt.2012.117. Epub 2012 Aug 29. Review.

3.

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, Haidar CE, Shen DD, Callaghan JT, Sadhasivam S, Prows CA, Kharasch ED, Skaar TC; Clinical Pharmacogenetics Implementation Consortium..

Clin Pharmacol Ther. 2014 Apr;95(4):376-82. doi: 10.1038/clpt.2013.254. Epub 2014 Jan 23. Review.

4.

Pharmacogenetic testing: time for clinical practice guidelines.

Amstutz U, Carleton BC.

Clin Pharmacol Ther. 2011 Jun;89(6):924-7. doi: 10.1038/clpt.2011.18. Epub 2011 Apr 20. Review. No abstract available.

PMID:
21508939
5.

[Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].

Stingl JC, Brockmöller J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1509-21. doi: 10.1007/s00103-013-1822-2. Review. German.

PMID:
24170080
6.

Clinical implementation of pharmacogenetics.

García-González X, Cabaleiro T, Herrero MJ, McLeod H, López-Fernández LA.

Drug Metab Pers Ther. 2016 Mar;31(1):9-16. doi: 10.1515/dmpt-2015-0031. Review.

7.

Pharmacogenomics: bridging the gap between science and practice.

Lee KC, Ma JD, Kuo GM.

J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):e1-14; quiz e15-7. doi: 10.1331/JAPhA.2010.09124. Review.

PMID:
20368146
8.

From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.

Wilffert B, Swen J, Mulder H, Touw D, Maitland-Van der Zee AH, Deneer V; KNMP working group Pharmacogenetics..

Int J Clin Pharm. 2013 Jun;35(3):369-75. doi: 10.1007/s11096-010-9446-1. Epub 2010 Nov 4. Review.

9.

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.

Abdel-Hamid IA, Andersson KE.

Pharmacogenomics. 2009 Oct;10(10):1625-44. doi: 10.2217/pgs.09.104. Review.

PMID:
19842936
10.

[Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].

Stingl JC, Just KS, Kaumanns K, Schurig-Urbaniak M, Scholl C, von Mallek D, Brockmöller J.

Internist (Berl). 2016 Mar;57(3):289-97. doi: 10.1007/s00108-015-0013-7. Review. German.

PMID:
26830424
11.

Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?

Vizirianakis IS.

Pharmacogenomics. 2005 Oct;6(7):701-11. Review.

PMID:
16207147
12.

Human genetic variation and personalized medicine.

Agrawal S, Khan F.

Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):7-28. Review.

PMID:
17877289
13.

Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.

Shahabi P, Dubé MP.

Int J Cardiol. 2015 Apr 1;184:772-95. doi: 10.1016/j.ijcard.2015.02.025. Epub 2015 Feb 25. Review.

PMID:
25838112
14.

[Pharmacogenomics and gene expression analysis. Functional genome research for individual application to patients].

Kassack MU.

Med Monatsschr Pharm. 2003 May;26(5):165-6. Review. German. No abstract available.

PMID:
12784508
15.

Pharmacogenomics and active surveillance for serious adverse drug reactions in children.

Loo TT, Ross CJ, Sistonen J, Visscher H, Madadi P, Koren G, Hayden MR, Carleton BC.

Pharmacogenomics. 2010 Sep;11(9):1269-85. doi: 10.2217/pgs.10.111. Review.

PMID:
20860467
16.

The emerging role of electronic medical records in pharmacogenomics.

Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM, McCarty CA, Davis RL, Skaar T, Lamba J, Savova G.

Clin Pharmacol Ther. 2011 Mar;89(3):379-86. doi: 10.1038/clpt.2010.260. Epub 2011 Jan 19. Review.

17.

Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Vegter S, Boersma C, Rozenbaum M, Wilffert B, Navis G, Postma MJ.

Pharmacoeconomics. 2008;26(7):569-87. Review.

PMID:
18563949
18.

Challenges of implementing pharmacogenetics in the critical care environment.

Freeman BD, McLeod HL.

Nat Rev Drug Discov. 2004 Jan;3(1):88-93. Review. No abstract available.

PMID:
14708023
19.

Pharmacogenomics and personalized medicine: mapping of future value creation.

Hu SX, Foster T, Kieffaber A.

Biotechniques. 2005 Oct;39(10 Suppl):S1-6. doi: 10.2144/000112048. Review. No abstract available.

20.

Pharmacogenetics, pharmacogenomics, and individualized medicine.

Ma Q, Lu AY.

Pharmacol Rev. 2011 Jun;63(2):437-59. doi: 10.1124/pr.110.003533. Epub 2011 Mar 24. Review.

Supplemental Content

Support Center